Hims & Hers Health, Inc. (HIMS)

Market Cap	4.76B
Revenue (ttm)	1.24B
Net Income (ttm)	101.26M
Shares Out	218.48M
EPS (ttm)	0.44
PE Ratio	49.02
Forward PE	42.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,719,593
Open	23.05
Previous Close	23.53
Day's Range	21.44 - 23.12
52-Week Range	7.67 - 30.44
Beta	1.06
Analysts	Buy
Price Target	21.54 (-1.15%)
Earnings Date	Nov 4, 2024

About HIMS

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2017
• Employees: 1,046
• Stock Exchange: NYSE
• Ticker Symbol: HIMS
• Website: https://www.forhims.com

Financial Performance

In 2023, Hims & Hers Health's revenue was $872.00 million, an increase of 65.49% compared to the previous year's $526.92 million. Losses were -$23.55 million, -64.15% less than in 2022.

Analyst Forecast

According to 13 analysts, the average rating for HIMS stock is "Buy." The 12-month stock price forecast is $21.54, which is a decrease of -1.15% from the latest price.

Price Target

$21.54

(-1.15% downside)

Analyst Consensus: Buy